CARDAMONIN (cas 18956-16-6) from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome

Add time:07/22/2019    Source:sciencedirect.com

Aberrant activation of NLRP3 inflammasome has been implicated in the pathogenesis of diverse inflammation-related diseases, and pharmacological molecules targeting NLRP3 inflammasome are of considerable value to identifying potential therapeutic interventions. CARDAMONIN (cas 18956-16-6) (CDN), the major active ingredient of the traditional Chinese medicinal herb Alpinia katsumadai, has exerted an excellent anti-inflammatory activity, but the mechanism underlying this role is not fully understood. Here, we show that CDN blocks canonical and noncanonical NLRP3 inflammasome activation triggered by multiple stimuli. Moreover, the suppression of CDN on inflammasome activation is specific to NLRP3, not to NLRC4 or AIM2 inflammasome. Besides, the inhibitory effect is not dependent on the expression of NF-κB-mediated inflammasome precursor proteins. We also demonstrate that CDN suppresses the NLRP3 inflammasome through blocking ASC oligomerization and speckle formation in a dose-dependent manner. Importantly, CDN improves the survival of mice suffering from lethal septic shock and attenuates IL-1β production induced by LPS in vivo, which is shown to be NLRP3 dependent. In conclusion, our results identify CDN as a broad-spectrum and specific inhibitor of NLRP3 inflammasome and a candidate therapeutic drug for treating NLRP3 inflammasome-driven diseases.

We also recommend Trading Suppliers and Manufacturers of CARDAMONIN (cas 18956-16-6). Pls Click Website Link as below: cas 18956-16-6 suppliers

Prev:Effect of CARDAMONIN (cas 18956-16-6) on hepatic ischemia reperfusion induced in rats: Role of nitric oxide
Next:Discovery of a highly active anticancer analogue of CARDAMONIN (cas 18956-16-6) that acts as an inducer of caspase-dependent apoptosis and modulator of the mTOR pathway)